Antibiotic prescribing for adults in ambulatory care in the USA, 2007–09
To determine patterns of ambulatory antibiotic prescribing in US adults, including the use of broad-spectrum versus narrow-spectrum agents, to provide a description of the diagnoses for which antibiotics are prescribed and to identify patient and physician factors associated with broad-spectrum anti...
Saved in:
Published in | Journal of antimicrobial chemotherapy Vol. 69; no. 1; pp. 234 - 240 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
Oxford Publishing Limited (England)
01.01.2014
|
Subjects | |
Online Access | Get full text |
ISSN | 0305-7453 1460-2091 1460-2091 |
DOI | 10.1093/jac/dkt301 |
Cover
Abstract | To determine patterns of ambulatory antibiotic prescribing in US adults, including the use of broad-spectrum versus narrow-spectrum agents, to provide a description of the diagnoses for which antibiotics are prescribed and to identify patient and physician factors associated with broad-spectrum antibiotic prescribing.
We used data for patients aged ≥ 18 years from the National Ambulatory and National Hospital Ambulatory Medical Care Surveys (2007-09). These are nationally representative surveys of patient visits to offices, hospital outpatient departments and emergency departments (EDs) in the USA, collectively referred to as ambulatory visits. We determined the types of antibiotics prescribed, including the use of broad-spectrum versus narrow-spectrum antibiotics, and examined prescribing patterns by diagnoses. We used multivariable logistic regression to identify factors associated with broad-spectrum antibiotic prescribing.
Antibiotics were prescribed during 101 million (95% CI: 91-111 million) ambulatory visits annually, representing 10% of all visits. Broad-spectrum agents were prescribed during 61% of visits in which antibiotics were prescribed. The most commonly prescribed antibiotics were quinolones (25% of antibiotics), macrolides (20%) and aminopenicillins (12%). Antibiotics were most commonly prescribed for respiratory conditions (41% of antibiotics), skin/mucosal conditions (18%) and urinary tract infections (9%). In multivariable analysis, among patients prescribed antibiotics, broad-spectrum agents were more likely to be prescribed than narrow-spectrum antibiotics for respiratory infections for which antibiotics are rarely indicated (e.g. bronchitis), during visits to EDs and for patients ≥ 60 years.
Broad-spectrum agents constitute the majority of antibiotics in ambulatory care. More than 25% of prescriptions are for conditions for which antibiotics are rarely indicated. Antibiotic stewardship interventions targeting respiratory and non-respiratory conditions are needed in ambulatory care. |
---|---|
AbstractList | To determine patterns of ambulatory antibiotic prescribing in US adults, including the use of broad-spectrum versus narrow-spectrum agents, to provide a description of the diagnoses for which antibiotics are prescribed and to identify patient and physician factors associated with broad-spectrum antibiotic prescribing.
We used data for patients aged ≥ 18 years from the National Ambulatory and National Hospital Ambulatory Medical Care Surveys (2007-09). These are nationally representative surveys of patient visits to offices, hospital outpatient departments and emergency departments (EDs) in the USA, collectively referred to as ambulatory visits. We determined the types of antibiotics prescribed, including the use of broad-spectrum versus narrow-spectrum antibiotics, and examined prescribing patterns by diagnoses. We used multivariable logistic regression to identify factors associated with broad-spectrum antibiotic prescribing.
Antibiotics were prescribed during 101 million (95% CI: 91-111 million) ambulatory visits annually, representing 10% of all visits. Broad-spectrum agents were prescribed during 61% of visits in which antibiotics were prescribed. The most commonly prescribed antibiotics were quinolones (25% of antibiotics), macrolides (20%) and aminopenicillins (12%). Antibiotics were most commonly prescribed for respiratory conditions (41% of antibiotics), skin/mucosal conditions (18%) and urinary tract infections (9%). In multivariable analysis, among patients prescribed antibiotics, broad-spectrum agents were more likely to be prescribed than narrow-spectrum antibiotics for respiratory infections for which antibiotics are rarely indicated (e.g. bronchitis), during visits to EDs and for patients ≥ 60 years.
Broad-spectrum agents constitute the majority of antibiotics in ambulatory care. More than 25% of prescriptions are for conditions for which antibiotics are rarely indicated. Antibiotic stewardship interventions targeting respiratory and non-respiratory conditions are needed in ambulatory care. To determine patterns of ambulatory antibiotic prescribing in US adults, including the use of broad-spectrum versus narrow-spectrum agents, to provide a description of the diagnoses for which antibiotics are prescribed and to identify patient and physician factors associated with broad-spectrum antibiotic prescribing.OBJECTIVESTo determine patterns of ambulatory antibiotic prescribing in US adults, including the use of broad-spectrum versus narrow-spectrum agents, to provide a description of the diagnoses for which antibiotics are prescribed and to identify patient and physician factors associated with broad-spectrum antibiotic prescribing.We used data for patients aged ≥ 18 years from the National Ambulatory and National Hospital Ambulatory Medical Care Surveys (2007-09). These are nationally representative surveys of patient visits to offices, hospital outpatient departments and emergency departments (EDs) in the USA, collectively referred to as ambulatory visits. We determined the types of antibiotics prescribed, including the use of broad-spectrum versus narrow-spectrum antibiotics, and examined prescribing patterns by diagnoses. We used multivariable logistic regression to identify factors associated with broad-spectrum antibiotic prescribing.METHODSWe used data for patients aged ≥ 18 years from the National Ambulatory and National Hospital Ambulatory Medical Care Surveys (2007-09). These are nationally representative surveys of patient visits to offices, hospital outpatient departments and emergency departments (EDs) in the USA, collectively referred to as ambulatory visits. We determined the types of antibiotics prescribed, including the use of broad-spectrum versus narrow-spectrum antibiotics, and examined prescribing patterns by diagnoses. We used multivariable logistic regression to identify factors associated with broad-spectrum antibiotic prescribing.Antibiotics were prescribed during 101 million (95% CI: 91-111 million) ambulatory visits annually, representing 10% of all visits. Broad-spectrum agents were prescribed during 61% of visits in which antibiotics were prescribed. The most commonly prescribed antibiotics were quinolones (25% of antibiotics), macrolides (20%) and aminopenicillins (12%). Antibiotics were most commonly prescribed for respiratory conditions (41% of antibiotics), skin/mucosal conditions (18%) and urinary tract infections (9%). In multivariable analysis, among patients prescribed antibiotics, broad-spectrum agents were more likely to be prescribed than narrow-spectrum antibiotics for respiratory infections for which antibiotics are rarely indicated (e.g. bronchitis), during visits to EDs and for patients ≥ 60 years.RESULTSAntibiotics were prescribed during 101 million (95% CI: 91-111 million) ambulatory visits annually, representing 10% of all visits. Broad-spectrum agents were prescribed during 61% of visits in which antibiotics were prescribed. The most commonly prescribed antibiotics were quinolones (25% of antibiotics), macrolides (20%) and aminopenicillins (12%). Antibiotics were most commonly prescribed for respiratory conditions (41% of antibiotics), skin/mucosal conditions (18%) and urinary tract infections (9%). In multivariable analysis, among patients prescribed antibiotics, broad-spectrum agents were more likely to be prescribed than narrow-spectrum antibiotics for respiratory infections for which antibiotics are rarely indicated (e.g. bronchitis), during visits to EDs and for patients ≥ 60 years.Broad-spectrum agents constitute the majority of antibiotics in ambulatory care. More than 25% of prescriptions are for conditions for which antibiotics are rarely indicated. Antibiotic stewardship interventions targeting respiratory and non-respiratory conditions are needed in ambulatory care.CONCLUSIONSBroad-spectrum agents constitute the majority of antibiotics in ambulatory care. More than 25% of prescriptions are for conditions for which antibiotics are rarely indicated. Antibiotic stewardship interventions targeting respiratory and non-respiratory conditions are needed in ambulatory care. To determine patterns of ambulatory antibiotic prescribing in US adults, including the use of broad-spectrum versus narrow-spectrum agents, to provide a description of the diagnoses for which antibiotics are prescribed and to identify patient and physician factors associated with broad-spectrum antibiotic prescribing. We used data for patients aged ≥18 years from the National Ambulatory and National Hospital Ambulatory Medical Care Surveys (2007-09). These are nationally representative surveys of patient visits to offices, hospital outpatient departments and emergency departments (EDs) in the USA, collectively referred to as ambulatory visits. We determined the types of antibiotics prescribed, including the use of broad-spectrum versus narrow-spectrum antibiotics, and examined prescribing patterns by diagnoses. We used multivariable logistic regression to identify factors associated with broad-spectrum antibiotic prescribing. Antibiotics were prescribed during 101 million (95% CI: 91-111 million) ambulatory visits annually, representing 10% of all visits. Broad-spectrum agents were prescribed during 61% of visits in which antibiotics were prescribed. The most commonly prescribed antibiotics were quinolones (25% of antibiotics), macrolides (20%) and aminopenicillins (12%). Antibiotics were most commonly prescribed for respiratory conditions (41% of antibiotics), skin/mucosal conditions (18%) and urinary tract infections (9%). In multivariable analysis, among patients prescribed antibiotics, broad-spectrum agents were more likely to be prescribed than narrow-spectrum antibiotics for respiratory infections for which antibiotics are rarely indicated (e.g. bronchitis), during visits to EDs and for patients ≥60 years. Broad-spectrum agents constitute the majority of antibiotics in ambulatory care. More than 25% of prescriptions are for conditions for which antibiotics are rarely indicated. Antibiotic stewardship interventions targeting respiratory and non-respiratory conditions are needed in ambulatory care. Objectives To determine patterns of ambulatory antibiotic prescribing in US adults, including the use of broad-spectrum versus narrow-spectrum agents, to provide a description of the diagnoses for which antibiotics are prescribed and to identify patient and physician factors associated with broad-spectrum antibiotic prescribing. Methods We used data for patients aged greater than or equal to 18 years from the National Ambulatory and National Hospital Ambulatory Medical Care Surveys (2007-09). These are nationally representative surveys of patient visits to offices, hospital outpatient departments and emergency departments (EDs) in the USA, collectively referred to as ambulatory visits. We determined the types of antibiotics prescribed, including the use of broad-spectrum versus narrow-spectrum antibiotics, and examined prescribing patterns by diagnoses. We used multivariable logistic regression to identify factors associated with broad-spectrum antibiotic prescribing. Results Antibiotics were prescribed during 101 million (95% CI: 91-111 million) ambulatory visits annually, representing 10% of all visits. Broad-spectrum agents were prescribed during 61% of visits in which antibiotics were prescribed. The most commonly prescribed antibiotics were quinolones (25% of antibiotics), macrolides (20%) and aminopenicillins (12%). Antibiotics were most commonly prescribed for respiratory conditions (41% of antibiotics), skin/mucosal conditions (18%) and urinary tract infections (9%). In multivariable analysis, among patients prescribed antibiotics, broad-spectrum agents were more likely to be prescribed than narrow-spectrum antibiotics for respiratory infections for which antibiotics are rarely indicated (e.g. bronchitis), during visits to EDs and for patients greater than or equal to 60 years. Conclusions Broad-spectrum agents constitute the majority of antibiotics in ambulatory care. More than 25% of prescriptions are for conditions for which antibiotics are rarely indicated. Antibiotic stewardship interventions targeting respiratory and non-respiratory conditions are needed in ambulatory care. |
Author | Pavia, Andrew T. Hicks, Lauri A. Hersh, Adam L. Shapiro, Daniel J. |
Author_xml | – sequence: 1 givenname: Daniel J. surname: Shapiro fullname: Shapiro, Daniel J. – sequence: 2 givenname: Lauri A. surname: Hicks fullname: Hicks, Lauri A. – sequence: 3 givenname: Andrew T. surname: Pavia fullname: Pavia, Andrew T. – sequence: 4 givenname: Adam L. surname: Hersh fullname: Hersh, Adam L. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23887867$$D View this record in MEDLINE/PubMed |
BookMark | eNqN0c1OGzEQB3CrAjUJ7aUPgFbigiqWjNdefxwj1AJVJA6Us-X1eluHzTrY3kNuvANvyJPUUcgFcejJGus3I4__M3Q0-MEi9A3DJQZJ5itt5u1jIoA_oSmmDMoKJD5CUyBQl5zWZIJmMa4AgNVMfEaTigjBBeNT9GsxJNc4n5wpNsFGE3I1_Ck6Hwrdjn2KhRsKvW7GXicftoXRwe6u0l9bPNwvLooKgL8-v4D8go473Uf79e08QQ8_f_y-uimXd9e3V4tlaWgNqWTUcAwUNxxEw1rRGtwRLBkHCya_sMol72RdEWsri0nDiNCYUKgIxcRIcoLO93M3wT-NNia1dtHYvteD9WNUmMqKUUYY_AflvGYgJM307B1d-TEMeZGdAiGASZHV6Zsam7Vt1Sa4tQ5bdfjQDGAPTPAxBtsp45JOzg8paNcrDGqXmcqZqX1mueX7u5bD1A_wP08ElJM |
CitedBy_id | crossref_primary_10_1016_j_cmi_2021_05_018 crossref_primary_10_1111_apm_13403 crossref_primary_10_3201_eid2012_140331 crossref_primary_10_1016_j_clinmicnews_2017_08_004 crossref_primary_10_1177_2333392814568345 crossref_primary_10_1002_jobm_201700497 crossref_primary_10_1016_S1473_3099_20_30332_7 crossref_primary_10_1093_jac_dku282 crossref_primary_10_1126_scitranslmed_aad6873 crossref_primary_10_1128_AAC_02039_13 crossref_primary_10_1136_bmjresp_2020_000866 crossref_primary_10_1002_advs_201901872 crossref_primary_10_1155_2023_2198259 crossref_primary_10_1016_j_jiph_2024_102613 crossref_primary_10_3399_bjgp17X689641 crossref_primary_10_1016_j_jaip_2020_04_059 crossref_primary_10_1093_cid_ciu422 crossref_primary_10_1021_acsinfecdis_3c00647 crossref_primary_10_1177_1945892418810293 crossref_primary_10_1126_scitranslmed_aay5067 crossref_primary_10_1007_s40258_021_00642_8 crossref_primary_10_1093_cid_civ076 crossref_primary_10_1093_ofid_ofw168 crossref_primary_10_3390_microbiolres14020041 crossref_primary_10_1001_jamanetworkopen_2024_56950 crossref_primary_10_1017_ash_2022_233 crossref_primary_10_1016_j_chest_2018_06_019 crossref_primary_10_1093_ajhp_zxab110 crossref_primary_10_1002_mus_27230 crossref_primary_10_1128_jcm_00869_24 crossref_primary_10_33880_ejfm_2021100202 crossref_primary_10_1093_jac_dku394 crossref_primary_10_1002_jac5_1528 crossref_primary_10_1080_13814788_2022_2083105 crossref_primary_10_7326_M20_7355 crossref_primary_10_1093_fampra_cmy094 crossref_primary_10_12677_ACM_2021_1110703 crossref_primary_10_1017_ice_2017_250 crossref_primary_10_1186_s12889_020_09971_0 crossref_primary_10_2174_1871526522666220118122516 crossref_primary_10_1007_s40506_018_0150_3 crossref_primary_10_1093_fampra_cmv019 crossref_primary_10_1007_s13669_017_0228_9 crossref_primary_10_3389_fpubh_2020_535668 crossref_primary_10_5863_1551_6776_24_1_39 crossref_primary_10_1377_hlthaff_2019_00545 crossref_primary_10_1016_j_midw_2020_102858 crossref_primary_10_1001_jamacardio_2021_4234 crossref_primary_10_3390_antibiotics10050601 crossref_primary_10_7326_M16_2766 crossref_primary_10_1016_j_nurpra_2020_06_003 crossref_primary_10_1177_1559827617700824 crossref_primary_10_1097_JXX_0000000000000705 crossref_primary_10_1377_hlthaff_2014_0383 crossref_primary_10_3390_antibiotics10040371 crossref_primary_10_1016_j_idc_2014_02_001 crossref_primary_10_1016_j_ajic_2019_01_027 crossref_primary_10_1002_jac5_1303 crossref_primary_10_1093_ofid_ofz466 crossref_primary_10_1177_1756287218783871 crossref_primary_10_1542_peds_2018_1056 crossref_primary_10_1016_j_idnow_2023_104719 crossref_primary_10_1016_j_cmi_2018_08_002 crossref_primary_10_1093_cid_ciz466 crossref_primary_10_1080_07853890_2020_1782460 crossref_primary_10_1080_14760584_2018_1488590 crossref_primary_10_1186_s13073_022_01025_x crossref_primary_10_3390_antibiotics9070389 crossref_primary_10_1007_s12070_022_03389_3 crossref_primary_10_1038_s41598_023_49734_6 crossref_primary_10_1097_PEC_0000000000002809 crossref_primary_10_1186_s40360_018_0237_y crossref_primary_10_3390_microorganisms11040952 crossref_primary_10_1007_s40267_021_00883_6 crossref_primary_10_1111_mve_12685 crossref_primary_10_1007_s00108_016_0069_z crossref_primary_10_1093_ofid_ofab224 crossref_primary_10_3390_antibiotics9090536 crossref_primary_10_1001_jamanetworkopen_2021_0235 crossref_primary_10_1093_ofid_ofae729 crossref_primary_10_1186_s13756_019_0592_5 crossref_primary_10_3389_fmicb_2021_660047 crossref_primary_10_1097_CCM_0000000000005085 crossref_primary_10_1038_s41591_019_0503_6 crossref_primary_10_1093_cid_ciaa1229 crossref_primary_10_5712_rbmfc11_38_1187 crossref_primary_10_3390_antibiotics11081027 crossref_primary_10_1016_j_jiph_2023_05_022 crossref_primary_10_3389_fphar_2020_591709 crossref_primary_10_5694_mja16_01042 crossref_primary_10_1093_intqhc_mzw117 crossref_primary_10_1007_s12445_017_0068_x crossref_primary_10_1136_bmjopen_2018_026251 crossref_primary_10_1542_peds_2021_051806 crossref_primary_10_1136_bmjgh_2018_001291 crossref_primary_10_15585_mmwr_mm6432a3 crossref_primary_10_3390_antibiotics12040762 crossref_primary_10_1021_acs_jmedchem_8b01561 crossref_primary_10_1128_msphere_00471_22 crossref_primary_10_3389_fcimb_2023_1223696 crossref_primary_10_1080_02813432_2017_1333321 crossref_primary_10_1016_j_mcna_2018_05_009 crossref_primary_10_3390_antibiotics11111559 crossref_primary_10_1016_j_jflm_2021_102207 crossref_primary_10_15585_mmwr_rr6506a1 crossref_primary_10_1093_cid_ciaa464 crossref_primary_10_1016_j_jcjq_2022_01_011 crossref_primary_10_1371_journal_ppat_1008211 crossref_primary_10_1016_j_ajic_2019_02_009 crossref_primary_10_1093_ofid_ofad585 crossref_primary_10_3389_fpubh_2022_830181 crossref_primary_10_54393_pjhs_v4i10_1011 crossref_primary_10_1093_jac_dkv328 crossref_primary_10_1002_phar_1761 crossref_primary_10_1186_s12909_024_05354_w crossref_primary_10_1038_ja_2017_62 crossref_primary_10_1001_jamanetworkopen_2022_7299 crossref_primary_10_1097_BPO_0000000000001152 crossref_primary_10_1186_s40064_015_1398_4 crossref_primary_10_3390_gidisord4030012 crossref_primary_10_1093_fampra_cmx118 crossref_primary_10_4274_BMJ_galenos_2022_2022_4_18 crossref_primary_10_1586_14737159_2015_1059278 crossref_primary_10_1377_hlthaff_2018_05091 crossref_primary_10_1177_0009922819879462 crossref_primary_10_3390_gidisord4040028 crossref_primary_10_1016_j_bcp_2016_10_001 crossref_primary_10_1097_CPM_0000000000000107 crossref_primary_10_1017_ash_2024_490 crossref_primary_10_1371_journal_pone_0188879 crossref_primary_10_1093_jac_dkv319 crossref_primary_10_1136_bmjopen_2016_012503 crossref_primary_10_1016_j_bioorg_2019_103364 crossref_primary_10_1016_S1473_3099_17_30593_5 crossref_primary_10_1016_j_cmi_2021_03_030 crossref_primary_10_2174_1871526522666220928115043 crossref_primary_10_1016_j_identj_2021_01_010 crossref_primary_10_1016_j_cgh_2021_08_049 crossref_primary_10_1007_s40121_015_0087_5 crossref_primary_10_1017_ice_2023_232 crossref_primary_10_1016_j_jcms_2017_08_010 crossref_primary_10_3390_antibiotics11081058 crossref_primary_10_1016_j_cej_2017_05_073 crossref_primary_10_1111_jphd_12245 crossref_primary_10_1097_WON_0000000000000612 crossref_primary_10_1016_j_seppur_2015_09_072 crossref_primary_10_1136_bmjopen_2016_012739 crossref_primary_10_1186_s12879_016_1990_4 crossref_primary_10_1128_ecosalplus_esp_0029_2023 crossref_primary_10_3389_fpubh_2022_936719 crossref_primary_10_1093_ofid_ofac599 crossref_primary_10_1093_infdis_jiv032 crossref_primary_10_7556_jaoa_2016_112 crossref_primary_10_1186_s12879_016_1559_2 crossref_primary_10_1093_jacamr_dlae117 crossref_primary_10_1002_pds_70036 crossref_primary_10_1111_ijcp_13042 crossref_primary_10_1017_ice_2016_315 crossref_primary_10_1093_ofid_ofw159 crossref_primary_10_1146_annurev_med_052716_030320 crossref_primary_10_1016_j_imr_2021_100726 crossref_primary_10_1038_s41533_021_00234_y crossref_primary_10_1097_INF_0000000000000652 crossref_primary_10_1097_PEC_0000000000002977 crossref_primary_10_1038_s41598_024_55166_7 crossref_primary_10_1111_jels_12316 crossref_primary_10_1136_bmjopen_2017_020583 crossref_primary_10_2807_1560_7917_ES_2016_21_26_30266 crossref_primary_10_1016_j_ijantimicag_2020_106193 crossref_primary_10_1186_s12875_022_01904_7 crossref_primary_10_1371_journal_pone_0225499 crossref_primary_10_4103_AIHB_AIHB_42_19 crossref_primary_10_1093_ofid_ofv113 crossref_primary_10_3390_antibiotics12030496 crossref_primary_10_1093_ofid_ofz039 crossref_primary_10_1017_ice_2017_59 crossref_primary_10_1038_s41579_020_0324_0 crossref_primary_10_1016_j_cger_2016_02_009 crossref_primary_10_1016_j_jaad_2017_09_010 crossref_primary_10_1016_j_ijid_2019_04_022 crossref_primary_10_1016_j_cmi_2022_02_035 crossref_primary_10_1016_j_molmed_2014_08_001 crossref_primary_10_1016_j_watres_2015_01_012 crossref_primary_10_1097_MCP_0000000000000567 crossref_primary_10_1093_jpids_piaa156 crossref_primary_10_1186_s12873_017_0138_1 crossref_primary_10_4103_sjcp_sjcp_20_22 crossref_primary_10_7196_SAMJ_2022_v112i7_16258 crossref_primary_10_1136_bmjopen_2019_029177 crossref_primary_10_1016_j_japh_2020_06_022 crossref_primary_10_1016_j_idc_2023_08_002 crossref_primary_10_1017_S0950268814003136 crossref_primary_10_3390_antibiotics11020218 crossref_primary_10_1371_journal_ppat_1006238 crossref_primary_10_1371_journal_pone_0249475 crossref_primary_10_1542_peds_2014_1781 crossref_primary_10_1002_14651858_CD012252_pub2 crossref_primary_10_3390_jcm6100094 crossref_primary_10_1111_ijcp_14113 crossref_primary_10_2903_j_efsa_2017_5017 crossref_primary_10_1128_CMR_00003_20 crossref_primary_10_3390_antibiotics13080724 crossref_primary_10_1097_MD_0000000000010527 crossref_primary_10_1128_msphere_00345_22 crossref_primary_10_3389_fmicb_2018_02957 crossref_primary_10_7326_M14_1933 crossref_primary_10_1177_0009922819834278 crossref_primary_10_1186_s13756_016_0146_z crossref_primary_10_1016_j_artmed_2024_102971 crossref_primary_10_1136_bmj_k3155 crossref_primary_10_3390_gidisord3040017 crossref_primary_10_1007_s15006_020_0342_x crossref_primary_10_1186_s12941_018_0278_5 crossref_primary_10_3389_fimmu_2024_1364954 crossref_primary_10_1016_j_amepre_2015_11_009 crossref_primary_10_1073_pnas_1918274117 crossref_primary_10_1128_AAC_02897_15 crossref_primary_10_33590_emj_10313090 crossref_primary_10_1093_fampra_cmy134 crossref_primary_10_1038_s41746_024_01400_5 crossref_primary_10_1093_cid_ciaa1173 crossref_primary_10_1007_s40274_013_0638_5 crossref_primary_10_1016_j_molstruc_2024_140349 crossref_primary_10_1016_j_idc_2019_10_004 crossref_primary_10_3390_ijerph16132385 crossref_primary_10_3390_diagnostics11112100 crossref_primary_10_1016_j_ajem_2018_07_052 crossref_primary_10_1177_00185787221150920 crossref_primary_10_1021_acssensors_3c00696 crossref_primary_10_1093_ajhp_zxab175 crossref_primary_10_1371_journal_pone_0223835 crossref_primary_10_1053_j_ackd_2018_09_003 crossref_primary_10_1371_journal_pone_0190522 crossref_primary_10_1093_cid_ciz1184 crossref_primary_10_3390_antibiotics11111478 crossref_primary_10_1007_s11606_018_4430_x crossref_primary_10_3399_bjgp18X700181 crossref_primary_10_3390_ijerph16010027 crossref_primary_10_1016_j_japh_2016_08_015 crossref_primary_10_17116_otorino20198405155 crossref_primary_10_1017_ice_2018_227 crossref_primary_10_1111_ijpp_12332 crossref_primary_10_1016_j_ajem_2016_03_024 crossref_primary_10_3390_antibiotics12020224 crossref_primary_10_18553_jmcp_2018_24_2_154 crossref_primary_10_3390_dj7010022 crossref_primary_10_3390_microorganisms10122326 crossref_primary_10_1097_INF_0000000000000767 crossref_primary_10_5125_jkaoms_2020_46_1_49 crossref_primary_10_1017_ice_2015_283 crossref_primary_10_1186_s12875_017_0619_z crossref_primary_10_1186_s12879_022_07768_7 crossref_primary_10_4103_jpbs_jpbs_243_22 crossref_primary_10_1093_cid_ciab602 crossref_primary_10_1016_j_mehy_2019_02_016 crossref_primary_10_1016_j_pcd_2018_07_001 crossref_primary_10_1007_s11908_018_0615_z crossref_primary_10_1128_CMR_00125_18 crossref_primary_10_3390_diagnostics12041008 crossref_primary_10_1007_s40121_017_0181_y crossref_primary_10_1017_ice_2017_3 crossref_primary_10_1186_s12889_019_7258_3 crossref_primary_10_1371_journal_pone_0185869 crossref_primary_10_1016_j_pec_2018_05_020 crossref_primary_10_1586_14787210_2016_1151353 crossref_primary_10_14423_SMJ_0000000000000795 crossref_primary_10_1517_17425255_2014_970166 crossref_primary_10_1093_ofid_ofab214 crossref_primary_10_1093_jpids_piu044 crossref_primary_10_1177_10600280211052677 crossref_primary_10_1016_j_japh_2017_03_014 crossref_primary_10_1080_01676830_2017_1423357 crossref_primary_10_1016_j_japh_2017_03_013 crossref_primary_10_1186_s40248_016_0072_1 crossref_primary_10_1016_j_japh_2015_11_013 crossref_primary_10_3389_fmicb_2021_657353 crossref_primary_10_3390_gidisord5020018 crossref_primary_10_1097_INF_0000000000001708 crossref_primary_10_1080_14787210_2021_1898946 crossref_primary_10_1001_jamapediatrics_2020_1990 crossref_primary_10_1111_jphs_12187 crossref_primary_10_1097_INF_0000000000002004 crossref_primary_10_1177_0018578720925386 crossref_primary_10_2139_ssrn_3178664 crossref_primary_10_1093_cid_ciz409 crossref_primary_10_3399_bjgpopen20X101082 crossref_primary_10_1039_D4AY01452A crossref_primary_10_1007_s15010_017_0997_0 crossref_primary_10_1177_2054270418774971 crossref_primary_10_1093_cid_ciz764 crossref_primary_10_1016_j_scitotenv_2022_157070 crossref_primary_10_1007_s40258_019_00516_0 crossref_primary_10_1128_AAC_00337_18 crossref_primary_10_1017_ice_2020_1245 crossref_primary_10_1093_ofid_ofab564 crossref_primary_10_1136_bmjopen_2020_039329 crossref_primary_10_1016_j_japh_2019_03_006 crossref_primary_10_1016_j_japh_2021_01_030 crossref_primary_10_1128_JCM_00968_19 crossref_primary_10_9778_cmajo_20170100 crossref_primary_10_1186_s13756_019_0478_6 crossref_primary_10_1016_j_jacc_2018_06_067 crossref_primary_10_1080_07853890_2018_1474002 crossref_primary_10_1371_journal_pone_0244585 crossref_primary_10_17826_cumj_681368 crossref_primary_10_1001_jamanetworkopen_2018_0243 crossref_primary_10_1017_ice_2021_21 crossref_primary_10_1093_cid_cix233 crossref_primary_10_1017_ice_2019_219 crossref_primary_10_1007_s12070_020_01878_x crossref_primary_10_1093_ofid_ofaa214 crossref_primary_10_3389_fphar_2022_767917 crossref_primary_10_1002_emp2_12767 crossref_primary_10_3390_antibiotics10020200 crossref_primary_10_1073_pnas_1819024116 crossref_primary_10_1093_ofid_ofz018 crossref_primary_10_1136_bmjopen_2019_031191 crossref_primary_10_1007_s00784_024_05497_6 crossref_primary_10_1001_jamaoto_2018_0667 crossref_primary_10_1002_mus_27346 crossref_primary_10_1016_j_jcms_2020_01_009 crossref_primary_10_1001_jamasurg_2020_6165 crossref_primary_10_1515_prilozi_2017_0023 crossref_primary_10_1016_j_ejogrb_2020_05_016 crossref_primary_10_1089_hs_2014_0083 crossref_primary_10_1038_s41467_020_16627_5 crossref_primary_10_4103_IJAM_IJAM_156_20 crossref_primary_10_1093_cid_ciu530 crossref_primary_10_1111_nyas_13289 crossref_primary_10_1093_cid_ciw831 crossref_primary_10_1093_ofid_ofaa568 crossref_primary_10_1001_jama_2018_19283 crossref_primary_10_1016_j_ejpb_2019_07_023 crossref_primary_10_1186_s12875_023_02039_z crossref_primary_10_1371_journal_pmed_1002825 crossref_primary_10_1016_j_anai_2022_12_023 crossref_primary_10_1017_ice_2015_49 |
Cites_doi | 10.1097/MLR.0b013e318178eabd 10.1016/S0140-6736(07)60235-9 10.1086/591126 10.1016/j.amjmed.2004.09.015 10.1097/MLR.0b013e3181653d2e 10.1111/j.1745-7599.2005.00072.x 10.1542/peds.2007-0819 10.1086/512810 10.1128/AAC.01581-06 10.1258/jrsm.99.7.358 10.1067/S0196-0644(01)70087-X 10.3201/eid0904.020268 10.1001/jama.2013.6287 10.1056/NEJMc1212055 10.1111/j.1525-1497.2005.0148.x 10.1197/j.aem.2006.10.096 10.1136/bmj.c2096 10.1001/jama.2009.1163 10.1056/NEJM199708143370701 10.1093/cid/ciq146 10.1542/peds.2011-1337 10.1001/archfami.7.1.45 10.1093/cid/ciq257 10.1093/cid/cir443 10.1001/jama.286.15.1849 10.7326/0003-4819-138-7-200304010-00008 10.1093/jac/dks445 10.1056/NEJMoa055356 10.1001/jama.289.21.2797-a 10.1001/archinternmed.2010.235 10.1086/319604 10.1001/jama.289.6.719 |
ContentType | Journal Article |
Copyright | Copyright Oxford Publishing Limited(England) Jan 2014 |
Copyright_xml | – notice: Copyright Oxford Publishing Limited(England) Jan 2014 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QL 7QO 7T7 7U7 7U9 8FD C1K FR3 H94 K9. M7N NAPCQ P64 7X8 |
DOI | 10.1093/jac/dkt301 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Toxicology Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Algology Mycology and Protozoology Abstracts (Microbiology C) Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Virology and AIDS Abstracts Technology Research Database Toxicology Abstracts ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management Nursing & Allied Health Premium Biotechnology Research Abstracts Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts Engineering Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic Virology and AIDS Abstracts Engineering Research Database |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1460-2091 |
EndPage | 240 |
ExternalDocumentID | 3166268901 23887867 10_1093_jac_dkt301 |
Genre | Research Support, U.S. Gov't, P.H.S Journal Article Feature |
GeographicLocations | United States United States--US |
GeographicLocations_xml | – name: United States – name: United States--US |
GrantInformation_xml | – fundername: PHS HHS grantid: IPA 110369 – fundername: PHS HHS grantid: 200-2010-M-36230 |
GroupedDBID | --- -E4 .2P .GJ .I3 .XZ .ZR 0R~ 18M 1TH 29J 2WC 3O- 4.4 482 48X 53G 5GY 5RE 5VS 5WA 5WD 70D AABZA AACZT AAJKP AAJQQ AAMVS AAOGV AAPGJ AAPNW AAPQZ AAPXW AARHZ AAUAY AAUQX AAVAP AAWDT AAWTL AAYXX ABDFA ABEJV ABEUO ABGNP ABIXL ABJNI ABKDP ABLJU ABNGD ABNHQ ABNKS ABPQP ABPTD ABQLI ABQNK ABSMQ ABVGC ABWST ABXVV ABZBJ ACCCW ACFRR ACGFO ACGFS ACIWK ACPQN ACPRK ACUFI ACUKT ACUTJ ACUTO ACVCV ACYHN ACZBC ADBBV ADEYI ADEZT ADGZP ADHKW ADHZD ADIPN ADMTO ADNBA ADOCK ADQBN ADRTK ADVEK ADYVW ADZXQ AEGPL AEHUL AEJOX AEKPW AEKSI AEMDU AEMQT AENEX AENZO AEPUE AETBJ AEWNT AFFNX AFFQV AFFZL AFIYH AFOFC AFRAH AFSHK AFXAL AFYAG AGINJ AGKEF AGKRT AGMDO AGORE AGQPQ AGQXC AGSYK AGUTN AHGBF AHMBA AHMMS AHXPO AI. AIAGR AIJHB AJBYB AJDVS AJEEA AJNCP ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX APIBT APJGH APWMN AQDSO AQKUS ASPBG ATGXG ATTQO AVNTJ AVWKF AXUDD AZFZN BAWUL BAYMD BCRHZ BEYMZ BHONS BTRTY BVRKM BZKNY C45 CAG CDBKE CITATION COF CS3 CZ4 DAKXR DIK DILTD DU5 D~K E3Z EBS ECGQY EE~ EIHJH EJD EMOBN ENERS F5P F9B FECEO FEDTE FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 H5~ HAR HH5 HVGLF HW0 HZ~ IOX J21 J5H JXSIZ KAQDR KBUDW KOP KQ8 KSI KSN L7B M-Z MBLQV MHKGH ML0 N9A NGC NOMLY NOYVH NTWIH NU- NVLIB O0~ O9- OAUYM OAWHX OBFPC OBS OCZFY ODMLO OJQWA OJZSN OK1 OPAEJ OVD OWPYF O~Y P2P PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD R44 RD5 RNI ROL ROX ROZ RUSNO RW1 RXO RZF RZO TCURE TEORI TJX TMA TR2 VH1 W8F WOQ X7H Y6R YAYTL YKOAZ YXANX ZGI ZKX ZXP ~91 ~A~ CGR CUY CVF ECM EIF NPM 7QL 7QO 7T7 7U7 7U9 8FD C1K FR3 H94 K9. M7N NAPCQ P64 7X8 |
ID | FETCH-LOGICAL-c450t-64c71041b708b6d8dc1f319670e0c00621f37f9523ee2e13b638a134023413c93 |
ISSN | 0305-7453 1460-2091 |
IngestDate | Fri Jul 11 15:16:36 EDT 2025 Fri Jul 11 03:30:07 EDT 2025 Mon Jun 30 16:44:38 EDT 2025 Mon Jul 21 05:19:27 EDT 2025 Tue Jul 01 03:17:04 EDT 2025 Thu Apr 24 23:08:36 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | prescribing patterns antibiotic resistance antibiotic stewardship |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c450t-64c71041b708b6d8dc1f319670e0c00621f37f9523ee2e13b638a134023413c93 |
Notes | SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 |
OpenAccessLink | https://academic.oup.com/jac/article-pdf/69/1/234/16863506/dkt301.pdf |
PMID | 23887867 |
PQID | 1470880698 |
PQPubID | 32192 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_1492646360 proquest_miscellaneous_1477560894 proquest_journals_1470880698 pubmed_primary_23887867 crossref_citationtrail_10_1093_jac_dkt301 crossref_primary_10_1093_jac_dkt301 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-01-01 |
PublicationDateYYYYMMDD | 2014-01-01 |
PublicationDate_xml | – month: 01 year: 2014 text: 2014-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Oxford |
PublicationTitle | Journal of antimicrobial chemotherapy |
PublicationTitleAlternate | J Antimicrob Chemother |
PublicationYear | 2014 |
Publisher | Oxford Publishing Limited (England) |
Publisher_xml | – name: Oxford Publishing Limited (England) |
References | Hersh ( key 20170511115459_DKT301C28) 2011; 128 Finkelstein ( key 20170511115459_DKT301C29) 2008; 121 Gupta ( key 20170511115459_DKT301C33) 2011; 52 Malhotra-Kumar ( key 20170511115459_DKT301C12) 2007; 369 Hicks ( key 20170511115459_DKT301C2) 2013; 368 Grijalva ( key 20170511115459_DKT301C17) 2009; 302 Steinman ( key 20170511115459_DKT301C1) 2003; 138 Piccirillo ( key 20170511115459_DKT301C35) 2001; 286 CDC ( key 20170511115459_DKT301C20) Liu ( key 20170511115459_DKT301C32) 2011; 52 Moran ( key 20170511115459_DKT301C31) 2006; 355 Van Eldere ( key 20170511115459_DKT301C23) 2007; 51 Gonzales ( key 20170511115459_DKT301C30) 2008; 46 Costelloe ( key 20170511115459_DKT301C10) 2010; 340 Mainous ( key 20170511115459_DKT301C18) 2003; 289 Seppala ( key 20170511115459_DKT301C24) 1997; 337 Steinman ( key 20170511115459_DKT301C6) 2009; 15 Goossens ( key 20170511115459_DKT301C3) 2007; 44 Ladd ( key 20170511115459_DKT301C5) 2005; 17 Mainous ( key 20170511115459_DKT301C7) 1998; 7 Gill ( key 20170511115459_DKT301C4) 2006; 38 CDC ( key 20170511115459_DKT301C27) European Surveillance of Antimicrobial Consumption ( key 20170511115459_DKT301C34) Zhang ( key 20170511115459_DKT301C36) 2010; 170 Steinman ( key 20170511115459_DKT301C26) 2003; 289 Ranji ( key 20170511115459_DKT301C14) 2008; 46 Gonzales ( key 20170511115459_DKT301C25) 2001; 37 Gerber ( key 20170511115459_DKT301C37) 2013; 309 Mainous ( key 20170511115459_DKT301C21) 2006; 99 Shehab ( key 20170511115459_DKT301C13) 2008; 47 McCaig ( key 20170511115459_DKT301C15) 2003; 9 Vanderweil ( key 20170511115459_DKT301C19) 2007; 14 Hicks ( key 20170511115459_DKT301C9) 2011; 53 Linder ( key 20170511115459_DKT301C22) 2005; 118 Roumie ( key 20170511115459_DKT301C16) 2005; 20 Lipsitch ( key 20170511115459_DKT301C11) 2001; 32 Suda ( key 20170511115459_DKT301C8) 2013; 68 |
References_xml | – volume: 46 start-page: 847 year: 2008 ident: key 20170511115459_DKT301C14 article-title: Interventions to reduce unnecessary antibiotic prescribing: a systematic review and quantitative analysis publication-title: Med Care doi: 10.1097/MLR.0b013e318178eabd – volume: 369 start-page: 482 year: 2007 ident: key 20170511115459_DKT301C12 article-title: Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study publication-title: Lancet doi: 10.1016/S0140-6736(07)60235-9 – volume: 47 start-page: 735 year: 2008 ident: key 20170511115459_DKT301C13 article-title: Emergency department visits for antibiotic-associated adverse events publication-title: Clin Infect Dis doi: 10.1086/591126 – volume: 118 start-page: 259 year: 2005 ident: key 20170511115459_DKT301C22 article-title: Fluoroquinolone prescribing in the United States: 1995 to 2002 publication-title: Am J Med doi: 10.1016/j.amjmed.2004.09.015 – volume: 46 start-page: 597 year: 2008 ident: key 20170511115459_DKT301C30 article-title: ‘Get smart Colorado’: impact of a mass media campaign to improve community antibiotic use publication-title: Med Care doi: 10.1097/MLR.0b013e3181653d2e – volume: 17 start-page: 416 year: 2005 ident: key 20170511115459_DKT301C5 article-title: The use of antibiotics for viral upper respiratory tract infections: an analysis of nurse practitioner and physician prescribing practices in ambulatory care, 1997–2001 publication-title: J Am Acad Nurse Pract doi: 10.1111/j.1745-7599.2005.00072.x – volume: 121 start-page: e15 year: 2008 ident: key 20170511115459_DKT301C29 article-title: Impact of a 16-community trial to promote judicious antibiotic use in Massachusetts publication-title: Pediatrics doi: 10.1542/peds.2007-0819 – volume-title: Get Smart: Know When Antibiotics Work ident: key 20170511115459_DKT301C20 – volume: 44 start-page: 1091 year: 2007 ident: key 20170511115459_DKT301C3 article-title: Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries publication-title: Clin Infect Dis doi: 10.1086/512810 – volume: 51 start-page: 3491 year: 2007 ident: key 20170511115459_DKT301C23 article-title: Risk factors for development of multiple-class resistance to Streptococcus pneumoniae strains in Belgium over a 10-year period: antimicrobial consumption, population density, and geographic location publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01581-06 – volume: 99 start-page: 358 year: 2006 ident: key 20170511115459_DKT301C21 article-title: Ambulatory antibiotic prescribing for acute bronchitis and cough and hospital admissions for respiratory infections: time trends analysis publication-title: J R Soc Med doi: 10.1258/jrsm.99.7.358 – volume: 37 start-page: 690 year: 2001 ident: key 20170511115459_DKT301C25 article-title: Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods publication-title: Ann Emerg Med doi: 10.1067/S0196-0644(01)70087-X – volume: 9 start-page: 432 year: 2003 ident: key 20170511115459_DKT301C15 article-title: Antimicrobial drug prescription in ambulatory care settings, United States, 1992–2000 publication-title: Emerg Infect Dis doi: 10.3201/eid0904.020268 – volume: 309 start-page: 2345 year: 2013 ident: key 20170511115459_DKT301C37 article-title: Effect of an outpatient antimicrobial stewardship intervention on broad-spectrum antibiotic prescribing by primary care pediatricians: a randomized trial publication-title: JAMA doi: 10.1001/jama.2013.6287 – volume: 368 start-page: 1461 year: 2013 ident: key 20170511115459_DKT301C2 article-title: US outpatient antibiotic prescribing, 2010 publication-title: New Engl J Med doi: 10.1056/NEJMc1212055 – volume: 20 start-page: 697 year: 2005 ident: key 20170511115459_DKT301C16 article-title: Trends in antibiotic prescribing for adults in the United States—1995 to 2002 publication-title: J Gen Intern Med doi: 10.1111/j.1525-1497.2005.0148.x – volume: 14 start-page: 366 year: 2007 ident: key 20170511115459_DKT301C19 article-title: Declining antibiotic prescriptions for upper respiratory infections, 1993–2004 publication-title: Acad Emerg Med doi: 10.1197/j.aem.2006.10.096 – volume: 340 start-page: c2096 year: 2010 ident: key 20170511115459_DKT301C10 article-title: Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis publication-title: BMJ doi: 10.1136/bmj.c2096 – volume: 302 start-page: 758 year: 2009 ident: key 20170511115459_DKT301C17 article-title: Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings publication-title: JAMA doi: 10.1001/jama.2009.1163 – volume: 337 start-page: 441 year: 1997 ident: key 20170511115459_DKT301C24 article-title: The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance publication-title: New Engl J Med doi: 10.1056/NEJM199708143370701 – volume: 52 start-page: e18 year: 2011 ident: key 20170511115459_DKT301C32 article-title: Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children publication-title: Clin Infect Dis doi: 10.1093/cid/ciq146 – volume: 128 start-page: 1053 year: 2011 ident: key 20170511115459_DKT301C28 article-title: Antibiotic prescribing in ambulatory pediatrics in the United States publication-title: Pediatrics doi: 10.1542/peds.2011-1337 – volume: 7 start-page: 45 year: 1998 ident: key 20170511115459_DKT301C7 article-title: The cost of antibiotics in treating upper respiratory tract infections in a Medicaid population publication-title: Arch Fam Med doi: 10.1001/archfami.7.1.45 – volume: 52 start-page: e103 year: 2011 ident: key 20170511115459_DKT301C33 article-title: International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases publication-title: Clin Infect Dis doi: 10.1093/cid/ciq257 – ident: key 20170511115459_DKT301C34 – volume: 53 start-page: 631 year: 2011 ident: key 20170511115459_DKT301C9 article-title: Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996–2003 publication-title: Clin Infect Dis doi: 10.1093/cid/cir443 – volume: 286 start-page: 1849 year: 2001 ident: key 20170511115459_DKT301C35 article-title: Impact of first-line vs second-line antibiotics for the treatment of acute uncomplicated sinusitis publication-title: JAMA doi: 10.1001/jama.286.15.1849 – volume: 138 start-page: 525 year: 2003 ident: key 20170511115459_DKT301C1 article-title: Changing use of antibiotics in community-based outpatient practice, 1991–1999 publication-title: Ann Intern Med doi: 10.7326/0003-4819-138-7-200304010-00008 – volume: 68 start-page: 715 year: 2013 ident: key 20170511115459_DKT301C8 article-title: A national evaluation of antibiotic expenditures by healthcare setting in the United States, 2009 publication-title: J Antimicrob Chemother doi: 10.1093/jac/dks445 – volume: 355 start-page: 666 year: 2006 ident: key 20170511115459_DKT301C31 article-title: Methicillin-resistant S. aureus infections among patients in the emergency department publication-title: New Engl J Med doi: 10.1056/NEJMoa055356 – volume: 38 start-page: 349 year: 2006 ident: key 20170511115459_DKT301C4 article-title: Use of antibiotics for adult upper respiratory infections in outpatient settings: a national ambulatory network study publication-title: Fam Med – volume: 289 start-page: 2797 year: 2003 ident: key 20170511115459_DKT301C18 article-title: Variation in use of broad-spectrum antibiotics for acute respiratory tract infection publication-title: JAMA doi: 10.1001/jama.289.21.2797-a – volume: 15 start-page: 861 year: 2009 ident: key 20170511115459_DKT301C6 article-title: Variation in outpatient antibiotic prescribing in the United States publication-title: Am J Manag Care – volume-title: Ambulatory Health Care Data ident: key 20170511115459_DKT301C27 – volume: 170 start-page: 1308 year: 2010 ident: key 20170511115459_DKT301C36 article-title: Ambulatory antibiotic use and prescription drug coverage in older adults publication-title: Arch Intern Med doi: 10.1001/archinternmed.2010.235 – volume: 32 start-page: 1044 year: 2001 ident: key 20170511115459_DKT301C11 article-title: Measuring and interpreting associations between antibiotic use and penicillin resistance in Streptococcus pneumoniae publication-title: Clin Infect Dis doi: 10.1086/319604 – volume: 289 start-page: 719 year: 2003 ident: key 20170511115459_DKT301C26 article-title: Predictors of broad-spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care publication-title: JAMA doi: 10.1001/jama.289.6.719 |
SSID | ssj0006568 |
Score | 2.5790827 |
Snippet | To determine patterns of ambulatory antibiotic prescribing in US adults, including the use of broad-spectrum versus narrow-spectrum agents, to provide a... Objectives To determine patterns of ambulatory antibiotic prescribing in US adults, including the use of broad-spectrum versus narrow-spectrum agents, to... |
SourceID | proquest pubmed crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 234 |
SubjectTerms | Adolescent Adult Adults Aged Aged, 80 and over Ambulatory care Ambulatory Care - methods Anti-Bacterial Agents - therapeutic use Antibiotics Drug Prescriptions - standards Drug Prescriptions - statistics & numerical data Drug Utilization - standards Drug Utilization - statistics & numerical data Female Humans Male Middle Aged Multivariate analysis Prescription drugs United States Young Adult |
Title | Antibiotic prescribing for adults in ambulatory care in the USA, 2007–09 |
URI | https://www.ncbi.nlm.nih.gov/pubmed/23887867 https://www.proquest.com/docview/1470880698 https://www.proquest.com/docview/1477560894 https://www.proquest.com/docview/1492646360 |
Volume | 69 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dbtMwFLbKkBA3CMZfYSAj0CTUpktix44vKwRMFUOV1kq9ixzX0cJoOtEUaVzxAlzxhjwJx7GTtGxDgxur9U_k-JwcH9vf-YzQK0l0BLOI8oiQmUdZFnqCSu5FXGoeSxHFypzoHn1kh1M6mkWzTufHBmppXaYD9e3SuJL_kSrkgVxNlOw_SLZ5KGTAb5AvpCBhSK8l42FhIj6WhnPV4FnBAKQNMNLwalRYV7lIzRVd5iy9gnk5YOP0eGiG12wi1oAH4osrfFUY_nyRV5xNhk_kRC9c4FazIX98Is9yGzNjo9Z7o0G7ra1OV3UQdt4bNgVj-dVidS2ssjdpmxh4dVUyl4veh8Hm5kRANzYnXFCWH3mcWj7ggbY2ljIfxGgv6aqNsL2vZUvZnEV1e512cg4tt9MFu285sT5JBen8tCSuD1v02n9Mew0Y0R7DkwRaJ7btDXQz5Lw69X8_axFDzEZWNu9Us90KcgBtD2zbbf_mikVL5bxM7qI7TpJ4aFXoHuroYhfdOnK4il20P7YM5ud9PGkD8lZ9vI_HLbf5-X00alUOb6gcBpXDVuVwXuBW5bBROZMF6oJB5frYKNyv7z998QBN372dvDn03HUcnqKRX3qMKnBHaZByP07ZPJ6rIDMGnPvaVyYWF_7yTEQh0TrUAUnBtMuAUPAKwVNSgjxEO8Wy0I8RDjQ4zpTRmGRzqjItwdFXKgpYmjKwHLSLXteDmCjHVW-uTPmcXBRWF71s6p5ZhpZLa-3VskjcF7yCZS-8SuwzEXfRi6YY7Ks5NJOFXq6rOhxWBbGgf6sjYF1hmPe66JGVc9MVcIljHjP-5FrdfIput5_RHtopv6z1M_B6y_R5pYu_ATn_qhw |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antibiotic+prescribing+for+adults+in+ambulatory+care+in+the+USA%2C+2007%E2%80%9309&rft.jtitle=Journal+of+antimicrobial+chemotherapy&rft.au=Shapiro%2C+Daniel+J.&rft.au=Hicks%2C+Lauri+A.&rft.au=Pavia%2C+Andrew+T.&rft.au=Hersh%2C+Adam+L.&rft.date=2014-01-01&rft.issn=0305-7453&rft.eissn=1460-2091&rft.volume=69&rft.issue=1&rft.spage=234&rft.epage=240&rft_id=info:doi/10.1093%2Fjac%2Fdkt301&rft.externalDBID=n%2Fa&rft.externalDocID=10_1093_jac_dkt301 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0305-7453&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0305-7453&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0305-7453&client=summon |